{"title":"Diabetes","description":"\u003cp class=\"MuiTypography-root MuiTypography-body1 Product-category-title_BrandCategoryName__BGcTR css-9l3uo3\"\u003eDiabetes\u003c\/p\u003e\n\u003c!----\u003e","products":[{"product_id":"humalog-kwk-pen-5s","title":"Humalog Kwik Pen Prefilled Pen 3.5Mg\/Ml (1 Box = 5 Prefilled Pen)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin Lispro\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes Management\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin lispro is a recombinant DNA sourced human insulin analogue. HUMALOG consists of zinc-insulin lispro crystals dissolved in a clear fluid. HUMALOG is used to control high blood sugar (glucose) in people with diabetes. HUMALOG takes effect more rapidly and has a shorter duration of activity as compared to regular insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin Lispro\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia , Diabetic Acidosis and Coma , lipoatrophy (depression in the skin), lipohypertrophy (enlargement or thickening of tissue), or localized cutaneous amyloidosis (skin lumps) , Allergy to Insulin: Patients occasionally experience redness, swelling, and itching at the site of injection of insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCorticosteroids, or thyroid replacement therapy , birth control pills, injections and patches , oral antidiabetic agents, salicylates (aspirin), sulfa antibiotics, certain antidepressants (monoamine oxidase inhibitors), beta-blockers, alcohol, ACE inhibitors and angiotensin II receptor blockers , thiazolidinediones (such as rosiglitazone and pioglitazone), alone or in combination with other antidiabetic agents (including insulin).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHUMALOG is a man-made fast-acting insulin used to control high blood sugar in adults and children with diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take HUMALOG if you: • are having an episode of low blood sugar (hypoglycemia). • have an allergy to HUMALOG or any of the ingredients in HUMALOG.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia or low blood sugar is the most common adverse effect experienced by insulin users. Blood glucose monitoring is recommended for all patients with diabetes. Uncorrected hypoglycemic or hyperglycemic reactions can cause loss of consciousness, coma or even death.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHUMALOG should not be used if it is not water-clear and colourless or if it has formed a deposit of solid particles on the wall of the cartridge.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAny change of insulin regimen should be made cautiously and only under medical supervision. Changes in purity, strength, brand (manufacturer), type (regular, NPH, etc), species (beef, pork, beef-pork, human), and\/or method of manufacture (recombinant DNA versus animal-source insulin) may result in the need for a change in dosage.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThis human insulin analogue differs from other insulins because it has a unique structure, a very quick onset of action and a short duration of activity. HUMALOG should be given within 15 minutes before a meal or when necessary shortly after a meal instead (within 20 minutes of the start of the meal). The short duration of action of HUMALOG means that if you have Type 1 diabetes you also need to use a longer-acting insulin to give the best glucose control (except when using an insulin infusion pump)\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore in a refrigerator (2°C–8°C). Do not Freeze . \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/div\u003e","brand":"ELI LILLY PAKISTAN PVT LTD.","offers":[{"title":"Default Title","offer_id":43892121698490,"sku":"Humalog-Kwik-Pen-Prefilled-Pen-5s","price":10830.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/humaloglispro3mlinjectionpen.jpg?v=1729526712"},{"product_id":"actrapid-hm-penfil-100iu-1s","title":"Actrapid Hm Penfil 100Iu 3Ml","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHuman Insulin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes Management\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe major effects of insulin on carbohydrate homoeostasis following its binding to specific cell-surface receptors on insulin-sensitive tissues, notably the liver, muscles and adipose tissue. It inhibits hepatic glucose production and enhances peripheral glucose disposal thereby reducing blood-glucose concentration. It also inhibits lipolysis thereby preventing the formation of ketone bodies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHuman Insulin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia : They may include cold sweat, cool pale skin, nervousness or tremor, anxious feeling, unusual tiredness or weakness, confusion, difficulty in concentration, headache, nausea and palpitation. Severe hypoglycemia may lead to unconsciousness and may result in temporary or permanent impairment of brain function or even death , Weight gain , Oedema and refraction anomalies , . Local hypersensitivity reactions (redness, swelling and itching at the injection site) , Lipodystrophy , generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBeta blocking agent Oral hypoglycemic agents (OHA), octreotide, monoamine oxidase inhibitor (MAOI), non selective beta blocking agents, angiotensin converting enzyme (ACE) inhibitors, salicylates, alcohol and alcohol steroids , Oral contraceptives, thiazides, glucocorticoids, thyroid hormones and sympathomimetics, danazol etc.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated for the treatment of : Patients with Type I diabetes mellitus. - Patients with Type II diabetes mellitus either alone or in combination with oral anti-diabetic agents. - Patients with gestational diabetes. - The emergency management of diabetic ketoacidosis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin is contraindicated in: - Patients with hypersensitivity to any components of this medication. - Patients with hypoglycemia. - Patients in coma due to hyperglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCare is also necessary during excessive exercise. Hypoglycemia caused by metabolic effects and increased insulin absorption is the usual response, but hyperglycemia may sometimes occur. Adjustment of insulin dosage may also be necessary if patients change their level of physical activity or change their usual diet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin requirements may be increased during illness or emotional disturbances.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of insulin necessitates monitoring of therapy, such as the testing of blood or urine for glucose concentrations and the urine for ketones, by the patient .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLocal reactions, characterised hypersensitivity may produce urticaria, angioedema and very rarely anaphylactic reactions. If continued therapy with insulin is essential, hyposensitisation procedures may need to be performed.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore in a refrigerator (2°C–8°C). Do not Freeze .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"NOVO NORDISK PAKISTAN LTD","offers":[{"title":"Default Title","offer_id":43892122747066,"sku":"actrapid-hm-penfil-100iu-1s","price":930.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/actrapidpenfillinsulin.jpg?v=1727527182"},{"product_id":"glucophage-xr750mg-30s","title":"Glucophage Xr Tablets 750Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e (1 Box = 3 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e• Vomiting • Stomach ache (abdominal pain) • Muscle cramps • A general feeling of not being well with severe tiredness • Difficulty in breathing • Reduced body temperature and heartbeat .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlcohol, Iodinated contrast agents , diuretics , corticosteroids , ACE inhibitors , sympathomimetics , NSAIDs , other hypoglycaemics . Inhibitors of OCT2 ( e.g , cimetidine, dolutegravir , ranolazine , trimethoprim ) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl is used to treat patients with type 2 diabetes (also called 'non-insulin dependent diabetes') when diet and exercise alone have not been enough to control your blood glucose levels. It is used particularly in overweight patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take Metformin :• if you are allergic (hypersensitive) to metformin or any of the other ingredients of this medicine • if you have liver problems• if you have severely reduced kidney function. • if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis or ketoacidosis. Ketoacidosis is a condition in which substances called 'ketone bodies' accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin on its own does not cause hypoglycaemia (a blood glucose level which is too low). However, if you take Metformin together with other medicines to treat diabetes that can cause hypoglycaemia (suchas sulphonylureas, insulin, meglitinides), there is a risk of hypoglycaemia. If you experience symptoms of hypoglycaemia such as weakness, dizziness, increased sweating, fast heart beating, vision disorders or difficulty in concentration, it usually helps to eat or drink something containing sugar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin decreases liver uptake of lactate which may increase the risk of lactic acidosis, especially in patients at risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Martin Dow","offers":[{"title":"Default Title","offer_id":43892128907450,"sku":"glucophage-xr750mg-30s","price":124.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/glucophage-xr750mg-30s.webp?v=1719696249"},{"product_id":"dapa-5mg-tablets-14s","title":"Dapa Tablets 5Mg  (1 Strip = 14 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 2 Strip of 14 tab)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInfections and infestations : Common: Vulvovaginitis, balanitis and related genital infections, Urinary tract infection (including pyelonephritis and urosepsis) Uncommon: Fungal infection Metabolism and nutrition disorders . Very common: Hypoglycaemia (when used with sulphonylurea or insulin) Uncommon: Volume depletion, Thirst Rare: Diabetic ketoacidosisNervous system disorders : Common: DizzinessGastrointestinal disorders : Uncommon: Constipation, Dry mouth Skin and subcutaneous tissue disorders Common: Rash Musculoskeletal and connective tissue disorders : Common: Back pain Not Known: Fracture of BoneRenal and urinary disorders Common: Dysuria, Polyuria Uncommon: Nocturia, Renal impairmentReproductive system and breast disorders Uncommon: Vulvovaginal pruritus, Pruritus genital\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eACE inhibitors , Flouroquinolones , Somatostatin Analogues , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eContraindications : History of a serious hypersensitivity reaction to dapagliflozin.Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt causes intravascular volume contraction. Symptomatic hypotension can occur after initiating dapagliflozin particularly in patients with impaired renal function (eGFR less than 60 mL\/min\/1.73 m2), elderly patients, or patients on loop diuretics. Before initiating dapagliflozin in patients, volume status should be assessed and corrected. Monitor for signs and symptoms of hypotension after initiating therapy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. It can increase the risk of hypoglycemia when combined with insulin or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with Dapagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should not be used in patients with active bladder cancer. In patients with prior history of bladder cancer, the benefits of glycemic control versus unknown risks for cancer recurrence with dapagliflozin should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt increases the risk of genital mycotic infections. Patients with a history of genital mycotic infections were more likely to develop genital mycotic infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HILTON PHARMA","offers":[{"title":"Default Title","offer_id":43892129136826,"sku":"dapa-5mg-tablets-14s","price":348.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/dapa5mg.jpg?v=1721062123"},{"product_id":"sita-met-tablets-50500-mg-14s","title":"Sita-Met Tablets 50\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSita-Met 50\/500mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892129202362,"sku":"sita-met-tablets-50500-mg-14s","price":289.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sita-met50_500mgTablet.jpg?v=1722926397"},{"product_id":"diamicron-mr-tablets-30-mg-2x10s","title":"Diamicron Mr Tablets 30Mg (1 Box = 1 Strip)(1 Strip = 20 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGliclazide\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is used when diet and exercise are not enough to control your blood glucose properly. It lowers blood glucose by increasing the amount of insulin (a hormone that controls blood glucose levels) produced by your pancreas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGliclazide\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGastro-intestinal: Abdominal pain, anal fissure, appetite increased, colitis, duodenal ulcer, epigastric fullness, faecal incontinence, flatulence, gastric irritation, gastroesophageal reflux, GI neoplasm benign, hemorrhoids, melena, dry mouth, oesophagitis, saliva increased, tooth ache, tooth disorder, vomiting. These reactions are generally dose-related and may disappear when the dose is reduced. Hearing and vestibular: hearing decreased, tinnitus. Liver and biliary: increased liver enzymes, hepatitis, hepatomegaly. Metabolic and nutritional: gout, glycosuria, hypercholesterolemia, hypertriglyceridemia, thirst. Cases of hepatic porphyria and disulfiram-like reactions have been described with sulfonylurea drugs. Clinical experience to date has shown that gliclazide 80 mg tablets has a low incidence of disulfiram type reactions. Musculo-skeletal: arthropathy, bursitis, hernia congenital, skeletal pain, spine malformation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLong-acting sulfonamides, tuberculostatics, NSAIDs, fibrates, monoamine oxidase inhibitors, salicylates, probenecid, beta-blockers, azole antifungal agents (oral and parenteral preparations), H2 receptor antagonists and angiotensin converting enzyme inhibitors , other antidiabetic agents (insulin, alpha glucosidase inhibitors, biguanides) , diuretics (thiazides, furosemide), corticosteroids, oral contraceptives (estrogen plus progestogen), chlorpromazine, ritodrine, salbutamol, terbutaline and nicotinic acid , Miconazole , Phenylbutazone , MAOIs , Chlorpromazine (neuroleptic agent) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is used to control blood glucose (sugar) in patients with Type II diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take if • You are allergic to: gliclazide, or any of the other ingredients • You have had an allergic reaction to any other sulphonylureas, or related medicines such as sulfa antibiotics or to thiazide diuretics (a type of fluid or water tablet).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients stabilized on gliclazide therapy, loss of blood sugar control may occur in cases of acute intercurrent disease or in stressful situations such as trauma or surgery. Under these conditions, discontinuation of gliclazide and administration of insulin should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of gliclazide must be considered as treatment in addition to proper dietary regimen and not as substitute for diet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAll sulfonylurea drugs can induce severe hypoglycemia. Particularly susceptible are elderly subjects, patients with impaired hepatic or renal function, those who are debilitated or malnourished and patients with primary or secondary adrenal insufficiency. Some cases may be severe and prolonged.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe efficacy of gliclazide, in reducing glucose to the desired level decreases over a long period of time in many patients: this may be due to progression in the severity of the diabetes, or to a reduced response to treatment. This phenomenon is known as secondary failure and should be distinguished from primary failure, when the drug is ineffective when prescribed as first-line treatment. Adequate dose adjustment and compliance with dietary measures should be considered before classifying the patient as secondary failure. If a loss of adequate blood glucose-lowering response to GLICLAZIDE is detected, the drug should be discontinued.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SERVIER PHARMA","offers":[{"title":"Default Title","offer_id":43892129235130,"sku":"diamicron-mr-tablets-30-mg-2x10s","price":396.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/07351.webp?v=1719696255"},{"product_id":"sita-tablets-50-mg-14s","title":"Sita 50Mg Tablets  (1 Strip  = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e (1 Box = 14 Tablets)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclicAMP. GLP1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUpper respiratory-tract infections, headache and nasopharyngitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin : Sitagliptin has a small effect on plasma digoxin concentrations. No dosage adjustment of digoxin is recommended. However, patients at risk of digoxin toxicity should be monitored for this when sitagliptin and digoxin are administered concomitantly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is indicated in patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control as: - Monotherapy- Dual Therapy : In combination with metformin HCl or with a sulphonylurea or with a PPAR? agonist (i.e., thiazolidinediones) when the treatment with the single agent alone with diet and exercise does not provide adequate glycemic control.- Triple Therapy : In combination with metformin HCl and a sulphonylurea or with metformin HCl and a PPAR? (i.e., thiazolidinediones) when dual therapy with these agents, with diet and exercise, does not provide adequate glycemic control. - Combination with Insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is contraindicated in: - Patients with known hypersensitivity to sitagliptin or any of the components of the product. - Patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. - Children below 18 years of age.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eWhen sitagliptin is used in combination with a sulphonylurea or with insulin, medications known to cause hypoglycemia the incidence of hypoglycemia increases when used in combination with a sulphonylurea or with insulin. Therefore, a lower dose of sulphonylurea or insulin may be required to reduce the risk of hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAn association between dipeptidyl peptidase-4 (DPP-4) inhibitor treatment and heart failure has been observed in trials for two other members of the DPP-4 inhibitor class. Consider the risks and benefits of Sitagliptin prior to initiating treatment in patients at risk for heart failure, such as those with a prior history of heart failure and a history of renal impairment, and observe these patients for signs and symptoms of heart failure during therapy. Advise patients of the characteristic symptoms of heart failure and to immediately report such symptoms. If heart failure develops, evaluate and manage according to current standards of care and consider discontinuation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIf a hypersensitivity reaction is suspected, discontinue this medicine, assess for other potential causes for the event, and institute alternative treatment for diabetes. Angioedema has also been reported with other DPP-4 inhibitors. Use caution in a patient with a history of angioedema with another DPP-4 inhibitor because it is unknown whether such patients will be predisposed to angioedema with sitagliptin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892129497274,"sku":"sita-tablets-50-mg-14s","price":272.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sita50mgTablet.jpg?v=1722926457"},{"product_id":"empaa-10mg-tablets-28s","title":"Empaa Tablets 10Mg (1 Box = 2 Strips) (1 Strip = 14 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased \/ glomerular filtration rate decreased.Rare : Diabetic ketoacidosis\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , thiazide and loop diuretics , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy :  When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is contraindicated in:• Patients with known hypersensitivity to empagliflozin or to any excipient of the product.• Severe renal impairment, end-stage renal disease or dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/div\u003e","brand":"HORIZON PHARMACEUTICALS","offers":[{"title":"Default Title","offer_id":43892129562810,"sku":"","price":0.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/19458.png?v=1719696260"},{"product_id":"amaryl-tablets-2-mg-3x10s","title":"Amaryl Tablets 2Mg (1 Strip = 15 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAmaryl 2mg tab 1Box=30tabs.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more insulin and induce increased activity of peripheral insulin intracellular receptor. However, as with other sulfonylureas, the mechanism by which glimepiride lowers blood glucose during long-term administration has not been clearly established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycaemin: Hypoglycaemia is one of the most widely reported adverse events with glimepiride in many clinical studies. The usual adverse events, other than hypoglycemia. considered to be possibly or probably related to more than 1% of patients treated with glimepiride are as follows: hypoglycemia, dizziness, asthenia, headache, and nausea.Other adverse events observed were: Gastrointestinal reactions: vomiting, gastrointestinal pain, and diarrhea have been reported, but the incidence in placebo-controlled trials was less than 1%. In rare cases, there may be an elevation of liver enzyme levels. Dermatologic reactions: Allergic skin reactions, e.g., pruritus, erythema, urticarial, and morbilliform or maculopapu ar eruptions, occur in less than 1% of treated patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxicase inhibitors, and beta adrenergic blocking agents , thiazides and their diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. It should not be used for the treatment of type-1diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride is contraindicated in patients who have known hypersensitivity to the drug and also in diabetic treated with insulin. Do not use in patients who have a history of an allergic ketoacidosis, with or without come. This condition should be reaction to sulphonamide derivatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may be severe. Ensure proper patient selection, dosing and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHemolytic Anemia can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non sulfonylurea alternative.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePotential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefits and treatment alternatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue Econid, assess for other causes , institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SANOFI-AVENTIS PAKISTAN LTD.","offers":[{"title":"Default Title","offer_id":43892129595578,"sku":"amaryl-tablets-2-mg-3x10s","price":324.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Amaryl2mgTablet30s.jpg?v=1720623795"},{"product_id":"novorapid-flexpen-3ml-5s","title":"Novorapid Flexpen Prefilled Pen 100Iu\/Ml (1 Pen)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eNovorapid Flexpen Prefilled Pen 100Iu\/Ml (1 Box = 5 Prefilled Pen)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin Aspart\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes Management\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is an insulin analogue used to treat diabetes. It will start to lower your blood sugar 10-20 minutes after you take it, it has a maximum effect between 1 and 3 hours and the effects last for 3-5 hours. Due to this short action it should normally be taken in combination with intermediate-acting or long-acting insulin preparations.The blood glucose lowering effect of insulin aspart is due to the facilitated uptake of glucose following binding of insulin to receptors on muscle and fat cells and to the simultaneous inhibition of glucose output from the liver.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin Aspart\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSigns of allergy Hives and rash may occur , lipodystrophy , Swollen joints , Diabetic retinopathy , Painful neuropathy (nerve related pain)\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eOther medicines for the treatment of diabetes , Monoamine oxidase inhibitors (MAOI) (used to treat depression) , Beta-blockers (used to treat high blood pressure) , Angiotensin converting enzyme (ACE) inhibitors (used to treat certain heart conditions or high blood pressure) , Salicylates (used to relieve pain and lower fever) , Anabolic steroids (such as testosterone) , Sulfonamides (used to treat infections) , Oral contraceptives (birth control pills) , Thiazides (used to treat high blood pressure or excessive fluid retention) , Glucocorticoids (such as ‘cortisone’ used to treat inflammation) , Thyroid hormones (used to treat thyroid gland disorders), Sympathomimetics (such as epinephrine [adrenaline], or salbutamol, terbutaline used to treat asthma) , Octreotide and lanreotide.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe treatment of patients with diabetes mellitus who require insulin for the control of hyperglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use if: * You feel a hypoglycemic reaction (low blood sugar) coming on. * You are allergic (hypersensitive) to insulin aspart, metacresol or any of the other ingredients in this insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAs with any insulin therapy, injection site reactions may occur and include pain, redness, hives, inflammation, bruising, swelling and itching. Continuous rotation of the injection site within a given area reduces the risk of developing these reactions. Reactions usually resolve in a few days to a few weeks. On rare occasions, injection site reactions may require discontinuation of Insulin Aspart.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInadequate dosing or discontinuation of treatment, especially in type 1 diabetes, may lead to hyperglycaemia and diabetic ketoacidosis. Usually the first symptoms of hyperglycaemia develop gradually over a period of hours or days. They include thirst, increased frequency of urination, nausea, vomiting, drowsiness, flushed dry skin, dry mouth, loss of appetite as well as acetone odour of breath. In type 1 diabetes, untreated hyperglycaemic events eventually lead to diabetic ketoacidosis, which is potentially lethal.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should be given immediately before a meal because of the fast onset of action (start of the meal should be not more than 5-10 minutes after injection ).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIf hypoglycemia or hypoglycemic reactions are not treated they can result in the loss of consciousness, coma or death.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore in a refrigerator (2°C–8°C). Do not Freeze .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"NOVO NORDISK PAKISTAN LTD","offers":[{"title":"Default Title","offer_id":43892129661114,"sku":"novorapid-flexpen-3ml-5s","price":1840.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/11145.webp?v=1719696264"},{"product_id":"glucophage-tablets-250-mg-5x10s","title":"Glucophage Tablets 250Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eGlucophage 250mg Tablet 1 Box = 5 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e• Vomiting • Stomach ache (abdominal pain) • Muscle cramps • A general feeling of not being well with severe tiredness • Difficulty in breathing • Reduced body temperature and heartbeat .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlcohol, Iodinated contrast agents , diuretics , corticosteroids , ACE inhibitors , sympathomimetics , NSAIDs , other hypoglycaemics . Inhibitors of OCT2 ( e.g , cimetidine, dolutegravir , ranolazine , trimethoprim ) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl is used to treat patients with type 2 diabetes (also called 'non-insulin dependent diabetes') when diet and exercise alone have not been enough to control your blood glucose levels. It is used particularly in overweight patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take Metformin :• if you are allergic (hypersensitive) to metformin or any of the other ingredients of this medicine • if you have liver problems• if you have severely reduced kidney function. • if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis or ketoacidosis. Ketoacidosis is a condition in which substances called 'ketone bodies' accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin on its own does not cause hypoglycaemia (a blood glucose level which is too low). However, if you take Metformin together with other medicines to treat diabetes that can cause hypoglycaemia (suchas sulphonylureas, insulin, meglitinides), there is a risk of hypoglycaemia. If you experience symptoms of hypoglycaemia such as weakness, dizziness, increased sweating, fast heart beating, vision disorders or difficulty in concentration, it usually helps to eat or drink something containing sugar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin decreases liver uptake of lactate which may increase the risk of lactic acidosis, especially in patients at risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Martin Dow","offers":[{"title":"Default Title","offer_id":43892129890490,"sku":"glucophage-tablets-250-mg-5x10s","price":22.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Glucophage250mgTablet.jpg?v=1721280251"},{"product_id":"sitaglu-met-tablets-50500-mg-14s","title":"Sitaglu Met Tablets 50\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSitaglu Met 50\/500mg Tablet 1 Box = 4 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HILTON PHARMA","offers":[{"title":"Default Title","offer_id":43892129956026,"sku":"sitaglu-met-tablets-50500-mg-14s","price":2536.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/SitagluMet50_500mgTablet.jpg?v=1722926006"},{"product_id":"neodipar-tablets-500-mg-5x10s","title":"Neodipar Tablets 500Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e1 BOX= 5 STRIPS\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e• Vomiting • Stomach ache (abdominal pain) • Muscle cramps • A general feeling of not being well with severe tiredness • Difficulty in breathing • Reduced body temperature and heartbeat .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlcohol, Iodinated contrast agents , diuretics , corticosteroids , ACE inhibitors , sympathomimetics , NSAIDs , other hypoglycaemics . Inhibitors of OCT2 ( e.g , cimetidine, dolutegravir , ranolazine , trimethoprim ) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl is used to treat patients with type 2 diabetes (also called 'non-insulin dependent diabetes') when diet and exercise alone have not been enough to control your blood glucose levels. It is used particularly in overweight patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take Metformin :• if you are allergic (hypersensitive) to metformin or any of the other ingredients of this medicine • if you have liver problems• if you have severely reduced kidney function. • if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis or ketoacidosis. Ketoacidosis is a condition in which substances called 'ketone bodies' accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin on its own does not cause hypoglycaemia (a blood glucose level which is too low). However, if you take Metformin together with other medicines to treat diabetes that can cause hypoglycaemia (suchas sulphonylureas, insulin, meglitinides), there is a risk of hypoglycaemia. If you experience symptoms of hypoglycaemia such as weakness, dizziness, increased sweating, fast heart beating, vision disorders or difficulty in concentration, it usually helps to eat or drink something containing sugar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin decreases liver uptake of lactate which may increase the risk of lactic acidosis, especially in patients at risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SANOFI-AVENTIS PAKISTAN LTD.","offers":[{"title":"Default Title","offer_id":43892129988794,"sku":"neodipar-tablets-500-mg-5x10s","price":34.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Neodipar500mgTablet.jpg?v=1722187403"},{"product_id":"diamicron-mr-tablets-60-mg-2x10s","title":"Diamicron Mr Tablets 60Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eDiamicron Mr Tablets 60Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGliclazide\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is used when diet and exercise are not enough to control your blood glucose properly. It lowers blood glucose by increasing the amount of insulin (a hormone that controls blood glucose levels) produced by your pancreas.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGliclazide\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGastro-intestinal: Abdominal pain, anal fissure, appetite increased, colitis, duodenal ulcer, epigastric fullness, faecal incontinence, flatulence, gastric irritation, gastroesophageal reflux, GI neoplasm benign, hemorrhoids, melena, dry mouth, oesophagitis, saliva increased, tooth ache, tooth disorder, vomiting. These reactions are generally dose-related and may disappear when the dose is reduced. Hearing and vestibular: hearing decreased, tinnitus. Liver and biliary: increased liver enzymes, hepatitis, hepatomegaly. Metabolic and nutritional: gout, glycosuria, hypercholesterolemia, hypertriglyceridemia, thirst. Cases of hepatic porphyria and disulfiram-like reactions have been described with sulfonylurea drugs. Clinical experience to date has shown that gliclazide 80 mg tablets has a low incidence of disulfiram type reactions. Musculo-skeletal: arthropathy, bursitis, hernia congenital, skeletal pain, spine malformation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLong-acting sulfonamides, tuberculostatics, NSAIDs, fibrates, monoamine oxidase inhibitors, salicylates, probenecid, beta-blockers, azole antifungal agents (oral and parenteral preparations), H2 receptor antagonists and angiotensin converting enzyme inhibitors , other antidiabetic agents (insulin, alpha glucosidase inhibitors, biguanides) , diuretics (thiazides, furosemide), corticosteroids, oral contraceptives (estrogen plus progestogen), chlorpromazine, ritodrine, salbutamol, terbutaline and nicotinic acid , Miconazole , Phenylbutazone , MAOIs , Chlorpromazine (neuroleptic agent) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is used to control blood glucose (sugar) in patients with Type II diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take if • You are allergic to: gliclazide, or any of the other ingredients • You have had an allergic reaction to any other sulphonylureas, or related medicines such as sulfa antibiotics or to thiazide diuretics (a type of fluid or water tablet).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients stabilized on gliclazide therapy, loss of blood sugar control may occur in cases of acute intercurrent disease or in stressful situations such as trauma or surgery. Under these conditions, discontinuation of gliclazide and administration of insulin should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of gliclazide must be considered as treatment in addition to proper dietary regimen and not as substitute for diet.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAll sulfonylurea drugs can induce severe hypoglycemia. Particularly susceptible are elderly subjects, patients with impaired hepatic or renal function, those who are debilitated or malnourished and patients with primary or secondary adrenal insufficiency. Some cases may be severe and prolonged.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe efficacy of gliclazide, in reducing glucose to the desired level decreases over a long period of time in many patients: this may be due to progression in the severity of the diabetes, or to a reduced response to treatment. This phenomenon is known as secondary failure and should be distinguished from primary failure, when the drug is ineffective when prescribed as first-line treatment. Adequate dose adjustment and compliance with dietary measures should be considered before classifying the patient as secondary failure. If a loss of adequate blood glucose-lowering response to GLICLAZIDE is detected, the drug should be discontinued.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SERVIER PHARMA","offers":[{"title":"Default Title","offer_id":43892130054330,"sku":"diamicron-mr-tablets-60-mg-2x10s","price":292.5,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/DiamicronMr60mgTablet.jpg?v=1721104466"},{"product_id":"sita-met-tablets-501000-mg-14s","title":"Sita Met Tablets 50\/1000Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSita Met Tablets 50\/1000Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892130283706,"sku":"sita-met-tablets-501000-mg-14s","price":297.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sita-met50_1000mgTablet.jpg?v=1722926572"},{"product_id":"glucophage-tablets-500-mg-5x10s","title":"Glucophage Tablets 500Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eGlucophage Tablets 500Mg (1 Box =  5 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its pharmacologic mechanisms of action are different from other classes of oral antihyperglycemic agents. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and day-long plasma insulin response may actually decrease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e• Vomiting • Stomach ache (abdominal pain) • Muscle cramps • A general feeling of not being well with severe tiredness • Difficulty in breathing • Reduced body temperature and heartbeat .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlcohol, Iodinated contrast agents , diuretics , corticosteroids , ACE inhibitors , sympathomimetics , NSAIDs , other hypoglycaemics . Inhibitors of OCT2 ( e.g , cimetidine, dolutegravir , ranolazine , trimethoprim ) .\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl is used to treat patients with type 2 diabetes (also called 'non-insulin dependent diabetes') when diet and exercise alone have not been enough to control your blood glucose levels. It is used particularly in overweight patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDo not take Metformin :• if you are allergic (hypersensitive) to metformin or any of the other ingredients of this medicine • if you have liver problems• if you have severely reduced kidney function. • if you have uncontrolled diabetes, with, for example, severe hyperglycaemia (high blood glucose), nausea, vomiting, diarrhoea, rapid weight loss, lactic acidosis or ketoacidosis. Ketoacidosis is a condition in which substances called 'ketone bodies' accumulate in the blood and which can lead to diabetic pre-coma. Symptoms include stomach pain, fast and deep breathing, sleepiness or your breath developing an unusual fruity smell.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin on its own does not cause hypoglycaemia (a blood glucose level which is too low). However, if you take Metformin together with other medicines to treat diabetes that can cause hypoglycaemia (suchas sulphonylureas, insulin, meglitinides), there is a risk of hypoglycaemia. If you experience symptoms of hypoglycaemia such as weakness, dizziness, increased sweating, fast heart beating, vision disorders or difficulty in concentration, it usually helps to eat or drink something containing sugar.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin decreases liver uptake of lactate which may increase the risk of lactic acidosis, especially in patients at risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin for a short time if you have a condition that may be associated with dehydration (significant loss of body fluids) such as severe vomiting, diarrhoea, fever, exposure to heat or if you drink less fluid than normal. Talk to your doctor for further instructions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStop taking Metformin and contact a doctor or the nearest hospital immediately if you experience some of the symptoms of lactic acidosis, as this condition may lead to coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Martin Dow Marker","offers":[{"title":"Default Title","offer_id":43892130349242,"sku":"glucophage-tablets-500-mg-5x10s","price":38.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Glucophage500mgTablet.jpg?v=1721280155"},{"product_id":"vildomet-50850mg-tablets-14s","title":"Vildomet Tablets 50Mg\/850Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eVildomet 50\/850mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HIGH-Q INTERNATIONAL.","offers":[{"title":"Default Title","offer_id":43892130382010,"sku":"vildomet-50-850mg-tablets-14s","price":225.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/VILDOMET50-850.jpg?v=1722790883"},{"product_id":"inosita-plus-50500mg-tablets-28s","title":"Inosita Plus Tablets 50\/500Mg  (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 4 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PHARMEVO PRIVATE LIMITED.","offers":[{"title":"Default Title","offer_id":43892130513082,"sku":"inosita-plus-50500mg-tablets-28s","price":236.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/inosita-plus-50500mg-tablets-28s.webp?v=1719696283"},{"product_id":"getformin-tablets-2500-mg-30s","title":"Getformin Tablets 2\/500Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e1box= 3 strips\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride, Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride: Glimepiride is a third generation sulphonylurea. The primary mechanism of action of glimepiride appears to be dependent on stimulating the release of insulin from functioni ng pancreatic beta cells. In addition, extrapancreatic effects (e.g. reduction of basal hepatic glucose production and increased peripheral tissue sensitivity to insulin and glucose uptake) may also play role in the activity of glimepiride.Metformin HCl: Metformin hydrochloride is a biguanide anti-diabetic, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its mode of action is thought to be multifactoral and includes delayed uptake of glucose from the intestinal tract, increased peripheral glucose utilization mediated by increased insulin sensitivity and inhibition of increased hepatic and renal gluconeogenesis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride, Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiarrhea, vomiting, metallic taste, rash, isolated transaminase elevations, cholestatic jaundice, allergic skin reactions, photosensitivity reactions, leukopenia, agranulocytosis, thrombocytopenia, hemolyticanemia, aplastic anemia, pancytopenia and blurred vision. Glimepiride appears to be associated with a low incidence of hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride: Salicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxidase inhibitors , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics and isoniazid , rifampicin, fluconazole, amiodarone, tolbutamide, diclofenac, ibuprofen, naproxen , clonidine and reserpine. Metformin HCl: Phenprocoumon, hyperglycemic agent (e.g. - thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channelblocking drugs and isoniazid), alcohol, furosemide, nifedipine and cationic drugs (amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim and cimetidine, vancomycin).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled with glimepiride or metformin HCl alone, or for those patients who have initially responded to glimepiride or metformin HCl alone and require additional glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride + Metformin HCl combination is contraindicated in:- Patients with known hypersensitivity to sulfonylurea or biguanide or any component of the drug.- Insulin-dependent diabetes mellitus.- Renal or hepatic failure.- Alcoholism.- NIDDM complicated by severe ketosis and acidosis.- Diabetic pre-coma and coma.- Patients undergoing surgery, after severe trauma or during infections.- Chronic obstructive pulmonary disease.- Coronary heart disease, cardiac failure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may occur if the patient's dietary intake is reduced or after accidental or deliberate overdose or after severe exercise, trauma and stress. Hypoglycemic symptoms can be reduced byprescribing a diabetic meal plan. Immediate intervention should be done if signs and symptoms of hypoglycemia occur. Adjust dose of drug according to blood and urinary glucose levels during the first few months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLactic acidosis is rare, but serious metabolic complication that can occur due to metformin accumulation. The incidence of lactic acidosis can and should be reduced by assessing also other associated risk factors such as poorly controlled diabetes, ketosis, prolonged fasting, excessive alcohol intake, hepatic insufficiency and any condition associated with hypoxia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAs metformin is excreted by the kidney, serum creatinine levels should be determined before initiating treatment and regularly thereafter.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSafety and effectiveness of the drug in children have not been established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892130742458,"sku":"getformin-tablets-2500-mg-30s","price":195.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/07027.webp?v=1719696286"},{"product_id":"sita-met-xr-50500mg-tablets-14s","title":"Sita-Met Xr Tablets 50Mg\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSita-Met Xr Tablets 50Mg\/500Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892130807994,"sku":"sita-met-xr-50500mg-tablets-14s","price":346.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sita-metXr50_500mgTablet.jpg?v=1722926200"},{"product_id":"trevia-tablets-50-mg-14s","title":"Trevia Tablets 50Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eTrevia 50mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclicAMP. GLP1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUpper respiratory-tract infections, headache and nasopharyngitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin : Sitagliptin has a small effect on plasma digoxin concentrations. No dosage adjustment of digoxin is recommended. However, patients at risk of digoxin toxicity should be monitored for this when sitagliptin and digoxin are administered concomitantly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is indicated in patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control as: - Monotherapy- Dual Therapy : In combination with metformin HCl or with a sulphonylurea or with a PPAR? agonist (i.e., thiazolidinediones) when the treatment with the single agent alone with diet and exercise does not provide adequate glycemic control.- Triple Therapy : In combination with metformin HCl and a sulphonylurea or with metformin HCl and a PPAR? (i.e., thiazolidinediones) when dual therapy with these agents, with diet and exercise, does not provide adequate glycemic control. - Combination with Insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is contraindicated in: - Patients with known hypersensitivity to sitagliptin or any of the components of the product. - Patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. - Children below 18 years of age.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eWhen sitagliptin is used in combination with a sulphonylurea or with insulin, medications known to cause hypoglycemia the incidence of hypoglycemia increases when used in combination with a sulphonylurea or with insulin. Therefore, a lower dose of sulphonylurea or insulin may be required to reduce the risk of hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAn association between dipeptidyl peptidase-4 (DPP-4) inhibitor treatment and heart failure has been observed in trials for two other members of the DPP-4 inhibitor class. Consider the risks and benefits of Sitagliptin prior to initiating treatment in patients at risk for heart failure, such as those with a prior history of heart failure and a history of renal impairment, and observe these patients for signs and symptoms of heart failure during therapy. Advise patients of the characteristic symptoms of heart failure and to immediately report such symptoms. If heart failure develops, evaluate and manage according to current standards of care and consider discontinuation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIf a hypersensitivity reaction is suspected, discontinue this medicine, assess for other potential causes for the event, and institute alternative treatment for diabetes. Angioedema has also been reported with other DPP-4 inhibitors. Use caution in a patient with a history of angioedema with another DPP-4 inhibitor because it is unknown whether such patients will be predisposed to angioedema with sitagliptin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892130840762,"sku":"trevia-tablets-50-mg-14s","price":243.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/04377.webp?v=1719696290"},{"product_id":"jentin-met-50500mg-tab","title":"Jentin Met Tablets 50Mg\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eJentin Met Tablets 50Mg\/500Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SEARLE PAKISTAN (PVT) LTD.","offers":[{"title":"Default Title","offer_id":43892131397818,"sku":"jentin-met-50500mg-tab","price":241.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/JentinMet50_500mgTablet.jpg?v=1721572769"},{"product_id":"amaryl-tablets-1-mg-3x10s","title":"Amaryl Tablets 1Mg (1 Strip = 15 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAmaryl 1mg Tablet 1Box=30tablets.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more insulin and induce increased activity of peripheral insulin intracellular receptor. However, as with other sulfonylureas, the mechanism by which glimepiride lowers blood glucose during long-term administration has not been clearly established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycaemin: Hypoglycaemia is one of the most widely reported adverse events with glimepiride in many clinical studies. The usual adverse events, other than hypoglycemia. considered to be possibly or probably related to more than 1% of patients treated with glimepiride are as follows: hypoglycemia, dizziness, asthenia, headache, and nausea.Other adverse events observed were: Gastrointestinal reactions: vomiting, gastrointestinal pain, and diarrhea have been reported, but the incidence in placebo-controlled trials was less than 1%. In rare cases, there may be an elevation of liver enzyme levels. Dermatologic reactions: Allergic skin reactions, e.g., pruritus, erythema, urticarial, and morbilliform or maculopapu ar eruptions, occur in less than 1% of treated patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxicase inhibitors, and beta adrenergic blocking agents , thiazides and their diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. It should not be used for the treatment of type-1diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride is contraindicated in patients who have known hypersensitivity to the drug and also in diabetic treated with insulin. Do not use in patients who have a history of an allergic ketoacidosis, with or without come. This condition should be reaction to sulphonamide derivatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may be severe. Ensure proper patient selection, dosing and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHemolytic Anemia can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non sulfonylurea alternative.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePotential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefits and treatment alternatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue Econid, assess for other causes , institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SANOFI-AVENTIS PAKISTAN LTD.","offers":[{"title":"Default Title","offer_id":43892131463354,"sku":"amaryl-tablets-1-mg-3x10s","price":165.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Amaryl1mgTablet30s.jpg?v=1720623607"},{"product_id":"treviamet-xr-50500mg-14s","title":"Treviamet-Xr Tablets 50Mg\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eTreviamet Xr 50\/500mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892131528890,"sku":"treviamet-xr-50500mg-14s","price":298.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/13086.webp?v=1719696297"},{"product_id":"inosita-plus-xr-50500mg-14s","title":"Inosita Plus Xr Tablets 50Mg\/500Mg  (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PHARMEVO PRIVATE LIMITED.","offers":[{"title":"Default Title","offer_id":43892131561658,"sku":"inosita-plus-xr-50500mg-14s","price":309.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/InositaplusXr50_500mgTablet.jpg?v=1721497267"},{"product_id":"treviamet-tablets-501000-mg-14s","title":"Treviamet Tablets 50\/1000Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eTreviamet 50\/1000mg Tablet 1 box = 4 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892131823802,"sku":"treviamet-tablets-501000-mg-28s","price":265.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/treviamet50-1000tab28s.jpg?v=1728572507"},{"product_id":"xiga-10mg-tablets-14s","title":"Xiga Tablets 10Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eXiga 10mg Tablet 1 box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInfections and infestations : Common: Vulvovaginitis, balanitis and related genital infections, Urinary tract infection (including pyelonephritis and urosepsis) Uncommon: Fungal infection Metabolism and nutrition disorders . Very common: Hypoglycaemia (when used with sulphonylurea or insulin) Uncommon: Volume depletion, Thirst Rare: Diabetic ketoacidosisNervous system disorders : Common: DizzinessGastrointestinal disorders : Uncommon: Constipation, Dry mouth Skin and subcutaneous tissue disorders Common: Rash Musculoskeletal and connective tissue disorders : Common: Back pain Not Known: Fracture of BoneRenal and urinary disorders Common: Dysuria, Polyuria Uncommon: Nocturia, Renal impairmentReproductive system and breast disorders Uncommon: Vulvovaginal pruritus, Pruritus genital\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eACE inhibitors , Flouroquinolones , Somatostatin Analogues , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eContraindications : History of a serious hypersensitivity reaction to dapagliflozin.Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt causes intravascular volume contraction. Symptomatic hypotension can occur after initiating dapagliflozin particularly in patients with impaired renal function (eGFR less than 60 mL\/min\/1.73 m2), elderly patients, or patients on loop diuretics. Before initiating dapagliflozin in patients, volume status should be assessed and corrected. Monitor for signs and symptoms of hypotension after initiating therapy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. It can increase the risk of hypoglycemia when combined with insulin or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with Dapagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should not be used in patients with active bladder cancer. In patients with prior history of bladder cancer, the benefits of glycemic control versus unknown risks for cancer recurrence with dapagliflozin should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt increases the risk of genital mycotic infections. Patients with a history of genital mycotic infections were more likely to develop genital mycotic infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892131856570,"sku":"xiga-10mg-tablets-14s","price":290.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/XIGA10MGTAB.jpg?v=1722784889"},{"product_id":"galvus-met-tablets-501000-mg-30s","title":"Galvus Met Tablets 50\/1000Mg  (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eGalvus Met Tablets 50\/1000Mg (1 Box = 3 Strips) \u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"NOVARTIS PHARMACEUTICALS","offers":[{"title":"Default Title","offer_id":43892131922106,"sku":"Galvus Met Tablets 50\/1000Mg  (1 Strip = 10 Tablets)","price":1024.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/GalvusMet50_1000mgTablet.jpg?v=1721280959"},{"product_id":"diampa-10mg-tablets-14s","title":"Diampa Tablets 10Mg  (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased \/ glomerular filtration rate decreased.Rare : Diabetic ketoacidosis\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , thiazide and loop diuretics , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is contraindicated in:• Patients with known hypersensitivity to empagliflozin or to any excipient of the product.• Severe renal impairment, end-stage renal disease or dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892132151482,"sku":"diampa-10mg-tablets-14s","price":223.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/15738.webp?v=1719696309"},{"product_id":"vildomet-50500mg-tab","title":"Vildomet Tablets 50Mg\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eVildomet Tablets 50Mg\/500Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HIGH-Q INTERNATIONAL.","offers":[{"title":"Default Title","offer_id":43892132184250,"sku":"vildomet-50500mg-tab-14s","price":179.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/VILDOMET50-500.jpg?v=1722790920"},{"product_id":"viglip-m-50-500mg","title":"Viglip-M Tablets 50Mg\/500Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eViglip-M Tablets 50Mg\/500Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"ATCO LABORATORIES LIMITED","offers":[{"title":"Default Title","offer_id":43892132282554,"sku":"viglip-m-50-500mg-14s","price":248.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/VIGLIP-M50-500.jpg?v=1722791093"},{"product_id":"vildos-tablets-50-mg-28s","title":"Vildos Tablets 50Mg  (1 Strip = 14 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eVildos Tablets 50Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMonotherapy Common: Dizziness. Uncommon: Hypoglycemia, headache, edema peripheral, constipation \u0026amp; arthralgia. Very Rare: Upper respiratory tract infection \u0026amp; nasopharyngitis. Combination with Metformin Common: Hypoglycemia, tremor, headache, dizziness \u0026amp; nausea. Uncommon: Fatigue. Combination with Sulfonylurea Common: Hypoglycemia, tremor, headache, dizziness \u0026amp; asthenia. Uncommon: Constipation. Very Rare: Nasopharyngitis. Combination with Thiazolidinedione Common: Weight increase \u0026amp; edema peripheral. Uncommon: Hypoglycemia, headache \u0026amp; asthenia. Combination with Metformin and Sulfonylurea Common: Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia. Combination with Insulin Common: Decreased blood glucose, headache, chills, nausea, gastroesophageal reflux disease. Uncommon: Diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin has a low potential for interactions with co-administered medicinal products. Since vildagliptin is not a cytochrome P (CYP) 450 enzyme substrate and does not inhibit or induce CYP450 enzymes, it isnot likely to interact with active substances that are substrates, inhibitors or inducers of these enzymes. As with other oral antidiabetic medicinal products the hypoglycemic effect of vildagliptin may be reduced by certain active substances, including thiazides, corticosteroids, thyroid products and sympathomimetics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin is indicated for the treatment of type 2 diabetes mellitus in adults:As monotherapy - In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.As dual oral therapy in combination with - Metformin, in patients with insufficient glycemic control despite maximal tolerated dose of monotherapy with metformin.- Sulfonylurea, in patients with insufficient glycemic control despite maximal tolerated dose of a sulfonylurea and for whom metformin is inappropriate due to contraindications or intolerance.- Thiazolidinedione, in patients with insufficient glycemic control and for whom the use of a thiazolidinedione is appropriate. As triple oral therapy in combination with- Sulfonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycemic control.Vildagliptin is also indicated for use in combination with insulin (with or without metformin) when diet and exercise plus a stable dose of insulin do not provide adequate glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin is contraindicated in patients with known hypersensitivity to vildagliptin or to any excipient of the product.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eRare cases of hepatic dysfunction (including hepatitis) have been reported. Liver function tests should be performed prior to the initiation of treatment. Liver function should be monitored during treatment with vildagliptin at three-month intervals during the first year and periodically thereafter. Patients who develop jaundice or other signs suggestive of liver dysfunction should discontinue vildagliptin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HIGH-Q INTERNATIONAL.","offers":[{"title":"Default Title","offer_id":43892132315322,"sku":"vildos-tablets-50-mg-28s","price":303.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/vildos50tablet28s.jpg?v=1728411792"},{"product_id":"vildomet-501000mg-tablets-14s","title":"Viptin MET Tablets 50Mg\/1000Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eViptin MET Tablets 50Mg\/1000Mg  (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SAMI PHARM (PVT) LTD.","offers":[{"title":"Default Title","offer_id":43892132675770,"sku":"vildomet-501000mg-tablets-14s","price":261.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/WhatsAppImage2026-08-06at3.32.49PM.jpg?v=1786030537"},{"product_id":"amaryl-tablets-3-mg-3x10s","title":"Amaryl Tablets 3Mg (1 Strip = 15 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cstrong\u003eAmaryl 3mg Tablet 1Box=30Tablets.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more insulin and induce increased activity of peripheral insulin intracellular receptor. However, as with other sulfonylureas, the mechanism by which glimepiride lowers blood glucose during long-term administration has not been clearly established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycaemin: Hypoglycaemia is one of the most widely reported adverse events with glimepiride in many clinical studies. The usual adverse events, other than hypoglycemia. considered to be possibly or probably related to more than 1% of patients treated with glimepiride are as follows: hypoglycemia, dizziness, asthenia, headache, and nausea.Other adverse events observed were: Gastrointestinal reactions: vomiting, gastrointestinal pain, and diarrhea have been reported, but the incidence in placebo-controlled trials was less than 1%. In rare cases, there may be an elevation of liver enzyme levels. Dermatologic reactions: Allergic skin reactions, e.g., pruritus, erythema, urticarial, and morbilliform or maculopapu ar eruptions, occur in less than 1% of treated patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxicase inhibitors, and beta adrenergic blocking agents , thiazides and their diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. It should not be used for the treatment of type-1diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride is contraindicated in patients who have known hypersensitivity to the drug and also in diabetic treated with insulin. Do not use in patients who have a history of an allergic ketoacidosis, with or without come. This condition should be reaction to sulphonamide derivatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may be severe. Ensure proper patient selection, dosing and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHemolytic Anemia can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non sulfonylurea alternative.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePotential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefits and treatment alternatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue Econid, assess for other causes , institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SANOFI-AVENTIS PAKISTAN LTD.","offers":[{"title":"Default Title","offer_id":43892132774074,"sku":"amaryl-tablets-3-mg-3x10s","price":516.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Amaryl3mgTablet30s.jpg?v=1720624001"},{"product_id":"viglip-m-50-850mg","title":"Viglip-M Tablets 50Mg\/850Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eViglip-M Tablets 50Mg\/850Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"ATCO LABORATORIES LIMITED","offers":[{"title":"Default Title","offer_id":43892132806842,"sku":"viglip-m-50-850mg-14s","price":248.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/VIGLIP-M50-850TAB.jpg?v=1722791053"},{"product_id":"jardy-10mg-tablets-14s","title":"Jardy Tablets 10Mg  (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eJardy Tablets 10Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased \/ glomerular filtration rate decreased.Rare : Diabetic ketoacidosis\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , thiazide and loop diuretics , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is contraindicated in:• Patients with known hypersensitivity to empagliflozin or to any excipient of the product.• Severe renal impairment, end-stage renal disease or dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892132872378,"sku":"jardy-10mg-tablets-14s","price":235.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Jardy10mgTablet.jpg?v=1721569629"},{"product_id":"getryl-tab-2-mg-3x10s","title":"Getryl Tablets 2Mg  (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 3 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more insulin and induce increased activity of peripheral insulin intracellular receptor. However, as with other sulfonylureas, the mechanism by which glimepiride lowers blood glucose during long-term administration has not been clearly established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycaemin: Hypoglycaemia is one of the most widely reported adverse events with glimepiride in many clinical studies. The usual adverse events, other than hypoglycemia. considered to be possibly or probably related to more than 1% of patients treated with glimepiride are as follows: hypoglycemia, dizziness, asthenia, headache, and nausea.Other adverse events observed were: Gastrointestinal reactions: vomiting, gastrointestinal pain, and diarrhea have been reported, but the incidence in placebo-controlled trials was less than 1%. In rare cases, there may be an elevation of liver enzyme levels. Dermatologic reactions: Allergic skin reactions, e.g., pruritus, erythema, urticarial, and morbilliform or maculopapu ar eruptions, occur in less than 1% of treated patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxicase inhibitors, and beta adrenergic blocking agents , thiazides and their diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. It should not be used for the treatment of type-1diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride is contraindicated in patients who have known hypersensitivity to the drug and also in diabetic treated with insulin. Do not use in patients who have a history of an allergic ketoacidosis, with or without come. This condition should be reaction to sulphonamide derivatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may be severe. Ensure proper patient selection, dosing and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHemolytic Anemia can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non sulfonylurea alternative.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePotential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefits and treatment alternatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue Econid, assess for other causes , institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892133134522,"sku":"getryl-tab-2-mg-3x10s","price":195.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/getryl-tab-2-mg-3x10s.webp?v=1719696328"},{"product_id":"glucovance-tablets-5500-mg-2x15s","title":"Glucovance Tablets 5\/500Mg  (1 Strip = 15 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eGlucovance Tablets 5\/500Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlibenclamide , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin Hydrochloride and Glibenclamide, two antihyperglycemic agents with complementary mechanisms of action, to improve glycemic control in patients with type 2 diabetes. Metformin Hydrochloride is an antihyperglycemic agent that improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Glibenclamide appears to lower blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlibenclamide , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiarrhoea, Headache, Nausea \/ Vomiting, Abdominal pain and Dizziness.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eWhen the drugs like the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid are administered to a patient receiving this medicine , the patient should be closely observed for loss of blood glucose control. When such drugs are withdrawn from a patient receiving this medicine, the patient should be observed closely for hypoglycemia. Metformin HCl is negligibly bound to plasma proteins and is, therefore, less likely to interact with highly protein-bound drugs such as salicylates, sulfonamides, chloramphenicol, and probenecid as compared to sulfonylureas, which are extensively bound to serum proteins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as initial therapy, as an adjunct to diet and exercise, to improve glycemic control in patients with type 2 diabetes whose hyperglycemia cannot be satisfactorily managed with diet and exercise alone. It is indicated as second-line therapy when diet, exercise, and initial treatment with a sulfonylurea or Metformin do not result in adequate glycemic control in patients with type 2 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin HCl and Glibenclamide is contraindicated in patients with: Renal disease or renal dysfunction (e.g., as suggested by serum creatinine levels =1.5 mg\/dL [males], =1.4 mg\/dL [females], or abnormal creatinine clearance) which may also result from conditions such as cardiovascular collapse (shock), acute myocardial infarction, and septicemia. Congestive heart failure requiring pharmacologic treatment. Known hypersensitivity to Metformin Hydrochloride or Glibenclamide. Acute or chronic metabolic acidosis, including diabetic ketoacidosis, with or without coma. Diabetic ketoacidosis should be treated with insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAs with other hypoglycemic agent, Metformin HCl and Glibenclamide is also capable of producing hypoglycemia or hypoglycemic symptoms, therefore, proper patient selection, dosing, and instructions are important to avoid potential hypoglycemic episodes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eRenal or hepatic insufficiency may cause elevated drug levels of both Metformin Hydrochloride and Glibenclamide and the hepatic insufficiency may also diminish gluconeogenic capacity, both of which increase the risk of hypoglycemic reactions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eElderly, debilitated, or malnourished patients and those with adrenal or pituitary insufficiency or alcohol intoxication are particularly susceptible to hypoglycemic effects. Hypoglycemia may be difficult to recognize in the elderly, and in people who are taking betaadrenergic blocking drug.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSafety and effectivenes in pediatric patients have not been established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Martin Dow","offers":[{"title":"Default Title","offer_id":43892133167290,"sku":"glucovance-tablets-5500-mg-2x15s","price":138.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Glucovance5_500mgTablet.jpg?v=1721278158"},{"product_id":"sitaglu-met-tablets-501000-mg-14s","title":"Sitaglu Met Tablets 50\/1000Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSitaglu Met 50\/1000mg Tablet 1 Box = 4 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HILTON PHARMA","offers":[{"title":"Default Title","offer_id":43892133232826,"sku":"sitaglu-met-tablets-501000-mg-14s","price":266.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sitaglumet50_1000mgTablet.jpg?v=1722926098"},{"product_id":"amaryl-m-tablets-sr-2500-mg-30s","title":"Amaryl MSR Tablets 2\/500Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAmaryl Msr 2\/500mg Tablet 1Box=30tablets.\u003c\/b\u003e\u003cb\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride, Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride: Glimepiride is a third generation sulphonylurea. The primary mechanism of action of glimepiride appears to be dependent on stimulating the release of insulin from functioni ng pancreatic beta cells. In addition, extrapancreatic effects (e.g. reduction of basal hepatic glucose production and increased peripheral tissue sensitivity to insulin and glucose uptake) may also play role in the activity of glimepiride.Metformin HCl: Metformin hydrochloride is a biguanide anti-diabetic, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Its mode of action is thought to be multifactoral and includes delayed uptake of glucose from the intestinal tract, increased peripheral glucose utilization mediated by increased insulin sensitivity and inhibition of increased hepatic and renal gluconeogenesis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride, Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiarrhea, vomiting, metallic taste, rash, isolated transaminase elevations, cholestatic jaundice, allergic skin reactions, photosensitivity reactions, leukopenia, agranulocytosis, thrombocytopenia, hemolyticanemia, aplastic anemia, pancytopenia and blurred vision. Glimepiride appears to be associated with a low incidence of hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride: Salicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxidase inhibitors , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics and isoniazid , rifampicin, fluconazole, amiodarone, tolbutamide, diclofenac, ibuprofen, naproxen , clonidine and reserpine. Metformin HCl: Phenprocoumon, hyperglycemic agent (e.g. - thiazides, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channelblocking drugs and isoniazid), alcohol, furosemide, nifedipine and cationic drugs (amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim and cimetidine, vancomycin).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes whose diabetes is not adequately controlled with glimepiride or metformin HCl alone, or for those patients who have initially responded to glimepiride or metformin HCl alone and require additional glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride + Metformin HCl combination is contraindicated in:- Patients with known hypersensitivity to sulfonylurea or biguanide or any component of the drug.- Insulin-dependent diabetes mellitus.- Renal or hepatic failure.- Alcoholism.- NIDDM complicated by severe ketosis and acidosis.- Diabetic pre-coma and coma.- Patients undergoing surgery, after severe trauma or during infections.- Chronic obstructive pulmonary disease.- Coronary heart disease, cardiac failure.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may occur if the patient's dietary intake is reduced or after accidental or deliberate overdose or after severe exercise, trauma and stress. Hypoglycemic symptoms can be reduced byprescribing a diabetic meal plan. Immediate intervention should be done if signs and symptoms of hypoglycemia occur. Adjust dose of drug according to blood and urinary glucose levels during the first few months.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLactic acidosis is rare, but serious metabolic complication that can occur due to metformin accumulation. The incidence of lactic acidosis can and should be reduced by assessing also other associated risk factors such as poorly controlled diabetes, ketosis, prolonged fasting, excessive alcohol intake, hepatic insufficiency and any condition associated with hypoxia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAs metformin is excreted by the kidney, serum creatinine levels should be determined before initiating treatment and regularly thereafter.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSafety and effectiveness of the drug in children have not been established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"SANOFI-AVENTIS PAKISTAN LTD.","offers":[{"title":"Default Title","offer_id":43892133265594,"sku":"amaryl-m-tablets-sr-2500-mg-30s","price":351.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Amarylmsr2-500mgtablet.jpg?v=1720623461"},{"product_id":"xenglu-10mg-tab-14s","title":"Xenglu Tablets 10Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eXenglu Tablets 10Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVery Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination.Uncommon : Volume depletion, dysuria and blood creatinine increased \/ glomerular filtration rate decreased.Rare : Diabetic ketoacidosis\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , thiazide and loop diuretics , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance.Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin is contraindicated in:• Patients with known hypersensitivity to empagliflozin or to any excipient of the product.• Severe renal impairment, end-stage renal disease or dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin.Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HILTON PHARMA","offers":[{"title":"Default Title","offer_id":43892133494970,"sku":"xenglu-10mg-tab-14s","price":196.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/xenglu10mgtablet14s.jpg?v=1728403369"},{"product_id":"xiga-5mg-tablets-14s","title":"Xiga Tablets 5Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eXiga 5mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSodium-glucose cotransporter 2 (SGLT2), expressed in the proximal renal tubules, is responsible for the majority of the reabsorption of filtered glucose from the tubular lumen. Dapagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, dapagliflozin reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDapagliflozin \u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInfections and infestations : Common: Vulvovaginitis, balanitis and related genital infections, Urinary tract infection (including pyelonephritis and urosepsis) Uncommon: Fungal infection Metabolism and nutrition disorders . Very common: Hypoglycaemia (when used with sulphonylurea or insulin) Uncommon: Volume depletion, Thirst Rare: Diabetic ketoacidosisNervous system disorders : Common: DizzinessGastrointestinal disorders : Uncommon: Constipation, Dry mouth Skin and subcutaneous tissue disorders Common: Rash Musculoskeletal and connective tissue disorders : Common: Back pain Not Known: Fracture of BoneRenal and urinary disorders Common: Dysuria, Polyuria Uncommon: Nocturia, Renal impairmentReproductive system and breast disorders Uncommon: Vulvovaginal pruritus, Pruritus genital\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eACE inhibitors , Flouroquinolones , Somatostatin Analogues , SGLT2 inhibitors\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eContraindications : History of a serious hypersensitivity reaction to dapagliflozin.Severe renal impairment, end-stage renal disease (ESRD), or patients on dialysis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt causes intravascular volume contraction. Symptomatic hypotension can occur after initiating dapagliflozin particularly in patients with impaired renal function (eGFR less than 60 mL\/min\/1.73 m2), elderly patients, or patients on loop diuretics. Before initiating dapagliflozin in patients, volume status should be assessed and corrected. Monitor for signs and symptoms of hypotension after initiating therapy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eInsulin and insulin secretagogues are known to cause hypoglycemia. It can increase the risk of hypoglycemia when combined with insulin or an insulin secretagogue. Therefore, a lower dose of insulin or insulin secretagogue may be required to minimize the risk of hypoglycemia when these agents are used in combination with Dapagliflozin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should not be used in patients with active bladder cancer. In patients with prior history of bladder cancer, the benefits of glycemic control versus unknown risks for cancer recurrence with dapagliflozin should be considered.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt increases the risk of genital mycotic infections. Patients with a history of genital mycotic infections were more likely to develop genital mycotic infections.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892133527738,"sku":"xiga-5mg-tablets-14s","price":196.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/XIGA5MG.jpg?v=1722784852"},{"product_id":"inosita-plus-501000mg-28s","title":"Inosita Plus Tablets 50Mg\/1000Mg  (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box = 4 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PHARMEVO PRIVATE LIMITED.","offers":[{"title":"Default Title","offer_id":43892133560506,"sku":"inosita-plus-501000mg-28s","price":329.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Inositaplus50_1000mgTablet.jpg?v=1721497163"},{"product_id":"sita-tablet-100mg","title":"Sita Tablets 100Mg (1 STRIP  = 7 TABLETS)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003e(1 Box  = 14 Tablets)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclicAMP. GLP1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUpper respiratory-tract infections, headache and nasopharyngitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin : Sitagliptin has a small effect on plasma digoxin concentrations. No dosage adjustment of digoxin is recommended. However, patients at risk of digoxin toxicity should be monitored for this when sitagliptin and digoxin are administered concomitantly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is indicated in patients with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control as: - Monotherapy- Dual Therapy : In combination with metformin HCl or with a sulphonylurea or with a PPAR? agonist (i.e., thiazolidinediones) when the treatment with the single agent alone with diet and exercise does not provide adequate glycemic control.- Triple Therapy : In combination with metformin HCl and a sulphonylurea or with metformin HCl and a PPAR? (i.e., thiazolidinediones) when dual therapy with these agents, with diet and exercise, does not provide adequate glycemic control. - Combination with Insulin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin is contraindicated in: - Patients with known hypersensitivity to sitagliptin or any of the components of the product. - Patients with type 1 diabetes or for the treatment of diabetic ketoacidosis. - Children below 18 years of age.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eWhen sitagliptin is used in combination with a sulphonylurea or with insulin, medications known to cause hypoglycemia the incidence of hypoglycemia increases when used in combination with a sulphonylurea or with insulin. Therefore, a lower dose of sulphonylurea or insulin may be required to reduce the risk of hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAn association between dipeptidyl peptidase-4 (DPP-4) inhibitor treatment and heart failure has been observed in trials for two other members of the DPP-4 inhibitor class. Consider the risks and benefits of Sitagliptin prior to initiating treatment in patients at risk for heart failure, such as those with a prior history of heart failure and a history of renal impairment, and observe these patients for signs and symptoms of heart failure during therapy. Advise patients of the characteristic symptoms of heart failure and to immediately report such symptoms. If heart failure develops, evaluate and manage according to current standards of care and consider discontinuation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIf a hypersensitivity reaction is suspected, discontinue this medicine, assess for other potential causes for the event, and institute alternative treatment for diabetes. Angioedema has also been reported with other DPP-4 inhibitors. Use caution in a patient with a history of angioedema with another DPP-4 inhibitor because it is unknown whether such patients will be predisposed to angioedema with sitagliptin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"C.C.L (PVT) LTD .","offers":[{"title":"Default Title","offer_id":43892133691578,"sku":"sita-tablet-100mg","price":416.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/Sita100mgTablet.jpg?v=1722926489"},{"product_id":"galvus-met-tablets-50850-mg-30s","title":"Galvus Met Tablets 50\/850Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eGalvus Met Tablets 50\/850Mg (1 Box = 3 Strips) \u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe administration of vildagliptin results in a rapid and complete inhibition of DPP-4 activity, resulting in increased fasting and postprandial endogenous levels of the incretin hormones GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide). Metformin HCl decreases hepatic glucose production through inhibition of gluconeogenesis and glycogenolysis, decrease intestinal absorption of glucose and improves insulin sensitivity by increasing peripheral glucose uptake and utilization.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia, tremor, headache, dizziness \u0026amp; nausea , Fatigue , Hypoglycemia, dizziness, tremor, hyperhidrosis \u0026amp; asthenia , Decreased blood glucose, headache, chills, nausea, gastro-esophageal reflux disease , diarrhea \u0026amp; flatulence.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThiazides, corticosteroids, thyroid products and sympathomimetics , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine, ranitidine, triamterene, trimethoprim, or vancomycin) , estrogens, oral contraceptives, phenytoin, nicotinic acid , alcohol.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl is indicated for the treatment of patients with Type 2 diabetes mellitus (T2DM). Vildagliptin + Metformin HCl is indicated as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin HCl alone or who are already treated with the combination of vildagliptin and metformin HCl, as separate tablets.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is contraindicated in: - Patients with known hypersensitivity to vildagliptin or metformin HCl or to any excipient of the product. - Diabetic ketoacidosis or diabetic pre-coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eVildagliptin + Metformin HCl combination is not substitute for insulin-requiring patients and should not be used in patients with type 1 diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIn diabetic patient, monitoring for skin disorders, such as blistering or ulceration, is recommended.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eUse of vildagliptin has been associated with a risk of developing acute pancreatitis. If pancreatitis is suspected, vildagliptin should be discontinued and if acute pancreatitis is confirmed, vildagliptin should not be restarted. Caution should be exercised in patients with a history of acute pancreatitis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment with metformin should be discontinued 48 hours before elective surgery with general anesthesia and should not usually be resumed earlier than 48 hours afterwards.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"NOVARTIS PHARMACEUTICALS","offers":[{"title":"Default Title","offer_id":43892133855418,"sku":"galvus-met-tablets-50-850-mg-3x10s","price":1008.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/GalvusMet50_850mgTablet.jpg?v=1721281039"},{"product_id":"empaa-m-xr-12-51000mg-tablet","title":"Empaa-M Xr Tablets 12.5\/1000Mg (1 Box = 2 Strips) (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin hydrochloride is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Empagliflozin Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMost common adverse reactions associated with empagliflozin (5% or greater incidence) were urinary tract infection and female genital mycotic infections. Most common adverse reactions associated with metformin (\u0026gt;5%) are diarrhea, nausea\/vomiting, flatulence, abdominal discomfort, indigestion, asthenia, and headache.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , Positive Urine Glucose Test , Interference with 1,5-anhydroglucitol (1,5-AG) Assay , ranolazine, vandetanib, dolutegravir, and cimetidine , zonisamide, acetazolamide or dichlorphenamide ,  corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid , Nifedipine\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both empagliflozin and metformin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should not be used  when Renal Impairment, ESRD, or on dialysis, Metabolic acidosis, including diabetic ketoacidosis, History of serious hypersensitivity reaction to empagliflozin or metformin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eKeep all medicines out of the reach and sight of children. Store in a cool, dry place, away from direct heat and light.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLactic Acidosis: There have been postmarketing cases of Metformin-associated lactic acidosis, including fatal cases. These cases had a subtle onset and were accompanied by nonspecific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence; however, hypothermia, hypotension, and resistant bradyarrhythmias have occurred with severe acidosis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypotension: Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating Empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic blood pressure, and in patients on diuretics. Before initiating this medicine , assess for volume contraction and correct volume status if indicated. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eKetoacidosis: Ketoacidosis, a serious life-threatening condition require urgent hospitalization in patients with type 1 and type 2 diabetes mellitus receiving sodium glucose co-transporter-2 (SGLT2) inhibitors, including Empagliflozin. Fatal cases of ketoacidosis have been reported in patients taking Empagliflozin.These medicines are not indicated for the treatment of patients with type 1 diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003c\/div\u003e","brand":"HORIZON PHARMACEUTICALS","offers":[{"title":"Default Title","offer_id":43892133920954,"sku":"","price":0.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/18871.png?v=1719696349"},{"product_id":"treviamet-50850-mg-tab","title":"Treviamet Tablets 50Mg\/850Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eTreviamet 50\/850mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892133986490,"sku":"treviamet-50850-mg-tab-14s","price":262.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/TreviaMet50mg_850mgTablet.jpg?v=1722873317"},{"product_id":"treviamet-xr-501000mg-14s","title":"Treviamet-Xr Tablets 50Mg\/1000Mg (1 Strip = 7 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eTreviamet-Xr 50\/1000mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eBy increasing and prolonging active incretin levels, Sitagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner. It is a biguanide with antihyperglycemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycemia.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin, Metformin\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.Uncommon: somnolence, diarrhea, upper abdominal pain and blood glucose decreased.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDigoxin , Furosemide , Nifedipine , Cationic drugs (e.g., amiloride, digoxin, morphine, procainamide, quinidine, quinine ranitidine, triamterene, trimethoprim, or vancomycin) , thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as: - Initial therapy in patients with type 2 diabetes mellitus to improve glycemic control when diet and exercise do not provide adequate glycemic control. As an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus inadequately controlled on Metformin HCl or Sitagliptin alone or in patients already being treated with the combination of Sitagliptin and Metformin HCl.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe combination of Sitagliptin and Metformin HCl is contraindicated in:- Patients with type 1 diabetes. -Patients with known hypersensitivity to Sitagliptin, Metformin HCl or any other component of the product. - Acute or chronic metabolic acidosis , including ketoacidosis, with or without coma.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSitagliptin+Metformin HCl are known to be substantially excreted by the kidney.Metformin HCl-related lactic acidosis increases with the degree of insufficiency of renal function, therefore, serum creatinine concentrations should be determined regularly.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSince impaired hepatic function has been associated with some cases of lactic acidosis, Sitagliptin+Metformin HCl should generally be avoided in patients with clinical or laboratory evidence of hepatic disease.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePatient receiving Sitagliptin+Metformin HCl in combination with a sulphonylurea or with insulin may be at risk for hypoglycemia. Therefore, a reduction in the dose of the sulphonylurea or insulin may be necessary.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAfter initiation of Sitagliptin, patients should be observed carefully for signs and symptoms of pancreatitis. If pancreatitis is suspected, Sitagliptin should promptly be discontinued and appropriate management should be initiated.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"GETZ PHARMA PAKISTAN","offers":[{"title":"Default Title","offer_id":43892134248634,"sku":"treviamet-xr-501000mg-14s","price":302.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/13273.webp?v=1719696354"},{"product_id":"zeenaryl-tablets-2-mg-2x10s","title":"Zeenaryl Tablets 2Mg (1 Strip = 10 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"SPECIFICATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eZeenaryl 2mg Tablet 1 Box = 2 Strips.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eThe primary mechanism of action of glimepiride in lowering blood glucose is by stimulating pancreatic beta cells to produce more insulin and induce increased activity of peripheral insulin intracellular receptor. However, as with other sulfonylureas, the mechanism by which glimepiride lowers blood glucose during long-term administration has not been clearly established.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"USAGE AND SAFETY\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycaemin: Hypoglycaemia is one of the most widely reported adverse events with glimepiride in many clinical studies. The usual adverse events, other than hypoglycemia. considered to be possibly or probably related to more than 1% of patients treated with glimepiride are as follows: hypoglycemia, dizziness, asthenia, headache, and nausea.Other adverse events observed were: Gastrointestinal reactions: vomiting, gastrointestinal pain, and diarrhea have been reported, but the incidence in placebo-controlled trials was less than 1%. In rare cases, there may be an elevation of liver enzyme levels. Dermatologic reactions: Allergic skin reactions, e.g., pruritus, erythema, urticarial, and morbilliform or maculopapu ar eruptions, occur in less than 1% of treated patients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSalicylates, sulfonamides, chloramphenicol, coumarins, probenecid, monoamine oxicase inhibitors, and beta adrenergic blocking agents , thiazides and their diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus. It should not be used for the treatment of type-1diabetes mellitus or diabetic ketoacidosis, as it would not be effective in these settings.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eGlimepiride is contraindicated in patients who have known hypersensitivity to the drug and also in diabetic treated with insulin. Do not use in patients who have a history of an allergic ketoacidosis, with or without come. This condition should be reaction to sulphonamide derivatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"PRECAUTIONS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypoglycemia may be severe. Ensure proper patient selection, dosing and instructions, particularly in at-risk populations (e.g., elderly, renally impaired) and when used with other anti-diabetic medications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"WARNINGS\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHemolytic Anemia can occur if glucose 6-phosphate dehydrogenase (G6PD) deficient. Consider a non sulfonylurea alternative.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003ePotential Increased Risk of Cardiovascular Mortality with Sulfonylureas: Inform patient of risks, benefits and treatment alternatives.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity Reactions: Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. Promptly discontinue Econid, assess for other causes , institute appropriate monitoring and treatment, and initiate alternative treatment for diabetes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper2___OSGQ\" id=\"ADDITIONAL INFORMATION\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HIGH-Q INTERNATIONAL.","offers":[{"title":"Default Title","offer_id":43892134314170,"sku":"zeenaryl-tablets-2-mg-2x10s","price":108.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/zeenaryl2mgtab.jpg?v=1722780524"},{"product_id":"xenglu-met-12-5-1000-mg-tb-14s","title":"Xenglu-Met Tablets 12.5Mg\/1000Mg (1 Strip = 14 Tablets)","description":"\u003cdiv class=\"productDescription_descriptionSectionGroup__cgws9 MuiBox-root css-0\"\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper__qrHVG\"\u003e\n\u003cdiv id=\"SPECIFICATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eXenglu-Met Tablets 12.5Mg\/1000Mg (1 Box = 2 Strips)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eSpecification\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eRequires Prescription (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eYes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eGenerics\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eUsed For\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eHow it works\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMetformin hydrochloride is an antihyperglycemic agent which improves glucose tolerance in patients with type 2 diabetes mellitus, lowering both basal and postprandial plasma glucose. Metformin decreases hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. Empagliflozin Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, Empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose, and thereby increases urinary glucose excretion.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"USAGE AND SAFETY\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eUsage And Safety\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDosage\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eEmpagliflozin , Metformin HCl\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eSide Effects\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eMost common adverse reactions associated with empagliflozin (5% or greater incidence) were urinary tract infection and female genital mycotic infections. Most common adverse reactions associated with metformin (\u0026gt;5%) are diarrhea, nausea\/vomiting, flatulence, abdominal discomfort, indigestion, asthenia, and headache.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eDrug Interactions\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eDiuretics , Positive Urine Glucose Test , Interference with 1,5-anhydroglucitol (1,5-AG) Assay , ranolazine, vandetanib, dolutegravir, and cimetidine , zonisamide, acetazolamide or dichlorphenamide , corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid , Nifedipine\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eIndication\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt is a combination of empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor and metformin, a biguanide, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus who are not adequately controlled on a regimen containing empagliflozin or metformin, or in patients already being treated with both empagliflozin and metformin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWhen not to Use\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eIt should not be used when Renal Impairment, ESRD, or on dialysis, Metabolic acidosis, including diabetic ketoacidosis, History of serious hypersensitivity reaction to empagliflozin or metformin.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"PRECAUTIONS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003ePrecautions\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePrecaution\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eKeep all medicines out of the reach and sight of children. Store in a cool, dry place, away from direct heat and light.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"WARNINGS\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eWarnings\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 1\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eLactic Acidosis: There have been postmarketing cases of Metformin-associated lactic acidosis, including fatal cases. These cases had a subtle onset and were accompanied by nonspecific symptoms such as malaise, myalgias, abdominal pain, respiratory distress, or increased somnolence; however, hypothermia, hypotension, and resistant bradyarrhythmias have occurred with severe acidosis.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 2\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eHypotension: Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating Empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic blood pressure, and in patients on diuretics. Before initiating this medicine , assess for volume contraction and correct volume status if indicated. Monitor for signs and symptoms of hypotension after initiating therapy and increase monitoring in clinical situations where volume contraction is expected.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eWarning 3\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eKetoacidosis: Ketoacidosis, a serious life-threatening condition require urgent hospitalization in patients with type 1 and type 2 diabetes mellitus receiving sodium glucose co-transporter-2 (SGLT2) inhibitors, including Empagliflozin. Fatal cases of ketoacidosis have been reported in patients taking Empagliflozin.These medicines are not indicated for the treatment of patients with type 1 diabetes mellitus.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv id=\"ADDITIONAL INFORMATION\" class=\"productDescription_descriptionWrapper2___OSGQ\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productTitle__Jflgt css-9l3uo3\"\u003e\u003cb\u003eAdditional Information\u003c\/b\u003e\u003c\/p\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003ePregnancy category\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eAlways consult your physician before using any medicine.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"productDescription_descriptionWrapper3__g15Bl\"\u003e\n\u003cp class=\"MuiTypography-root MuiTypography-body1 productDescription_productSubTitle__IJgZU css-9l3uo3\"\u003e\u003cb\u003eStorage (YES\/NO)\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eStore this medicine at room temperature, away from direct light and heat.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"HILTON PHARMA","offers":[{"title":"Default Title","offer_id":43892134346938,"sku":"xenglu-met-12-5-1000-mg-tb-28s","price":516.0,"currency_code":"PKR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0658\/7511\/6218\/files\/xengluMet12.5-1000.jpg?v=1722781518"}],"url":"https:\/\/multanpluspharmacy.com\/collections\/diabetes.oembed?page=19","provider":"Multan Plus Pharmacy","version":"1.0","type":"link"}